Asthma Trial, Recruiting (NCT06015256)

Asthma Trial, Recruiting NCT06015256 Sponsor: Institut National de la Santé Et de la Recherche Médicale, France Condition: Asthma

Printed from Voxsanity (voxsanity.com.au) — NCT06015256 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Asthma

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have read, understood, and signed a consent form before any study procedures begin
You are covered by or eligible for a social security/health insurance scheme
You are 18 years of age or older
(For people with asthma) You have been diagnosed with severe asthma, confirmed by a lung specialist at a specialist centre
(For people with controlled asthma) A lung specialist at a specialist centre has confirmed your asthma is currently well controlled
(For people with uncontrolled asthma without a flare-up) A lung specialist at a specialist centre has confirmed your asthma is currently not well controlled
(For people with uncontrolled asthma with a flare-up) You are currently experiencing an asthma flare-up
(For healthy volunteers) You do not have asthma or any inflammatory condition

Who may not be able to join:

You are under any form of legal protection order
You are a minor, under guardianship or trusteeship, or have had your personal freedoms restricted by a court
You are currently known to be pregnant, or become pregnant during the study (confirm with trial site)
You are unwilling or unable to follow the requirements of the study
You are a current or former smoker with a significant smoking history of more than 15 pack-years (confirm with trial site)
You have taken anti-inflammatory painkillers (such as ibuprofen) or opioid medications in the 10 days before joining the study
(For people with asthma) You have another long-term inflammatory condition in addition to asthma
(For healthy volunteers) You have any inflammatory condition
(For healthy volunteers) Your total IgE level (a marker measured in your blood sample) is greater than 100 kU/L (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +334.91.96.58.64

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06015256

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France

Phase: Not Applicable

Status: Recruiting

Condition: Asthma

Trial contact: +334.91.96.58.64

More information: https://clinicaltrials.gov/study/NCT06015256

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have read, understood, and signed a consent form before any study procedures begin
You are covered by or eligible for a social security/health insurance scheme
You are 18 years of age or older
(For people with asthma) You have been diagnosed with severe asthma, confirmed by a lung specialist at a specialist centre
(For people with controlled asthma) A lung specialist at a specialist centre has confirmed your asthma is currently well controlled
(For people with uncontrolled asthma without a flare-up) A lung specialist at a specialist centre has confirmed your asthma is currently not well controlled
(For people with uncontrolled asthma with a flare-up) You are currently experiencing an asthma flare-up
(For healthy volunteers) You do not have asthma or any inflammatory condition

Who may not be able to join:

You are under any form of legal protection order
You are a minor, under guardianship or trusteeship, or have had your personal freedoms restricted by a court
You are currently known to be pregnant, or become pregnant during the study (confirm with trial site)
You are unwilling or unable to follow the requirements of the study
You are a current or former smoker with a significant smoking history of more than 15 pack-years (confirm with trial site)
You have taken anti-inflammatory painkillers (such as ibuprofen) or opioid medications in the 10 days before joining the study
(For people with asthma) You have another long-term inflammatory condition in addition to asthma
(For healthy volunteers) You have any inflammatory condition
(For healthy volunteers) Your total IgE level (a marker measured in your blood sample) is greater than 100 kU/L (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France

Registry

ClinicalTrials.gov

Start date

7 September 2023

Est. completion

1 September 2028

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Changes in expression of one or more molecules on the surface of NK cells

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov